
RegDesk is the most comprehensive AI-enabled RIMS platform for Medical Devices, Pharmaceuticals, and IVD companies.
• Our proprietary Regulatory Intelligence for over 120+ countries is translated and accessible in a standard format. In addition, it provides alerts on evolving regulatory changes
• Our AI-powered Application Builder allows RA teams to prepare and publish global applications in 1/10th of the time
• Our Change Assessment capability helps RA teams understand the impact of the change(s) on an existing product(s) and the action required
• Our Distributor Collaboration provides seamless workflow solutions to interact, communicate, and share documents with external business partners
• Our Standards Management makes it easy for RA teams to search and manage not only international but also country-specific standards
• Our Tracking & Reporting functionality allows teams to track regulatory projects across the globe, receive renewal notifications, and generate reports on KPIs within seconds
For more information, visit our website.
Learn more

QBench is a cloud-based Laboratory Information Management System (LIMS) designed to help laboratories manage samples, workflows, data, inventory, reporting, quality processes, and client interactions in one platform.
Labs use QBench to manage operations from order placement and sample processing through results and automated reporting. The platform is highly configurable, allowing laboratories to build workflows, define custom data fields, and automate processes around the way their lab operates.
QBench helps reduce manual work by connecting instruments, software, and other systems through file parsers and a robust API. These integrations can automate data transfer, reduce repetitive data entry, and lower the risk of transcription errors.
Key capabilities include sample and workflow management, configurable workflows and custom fields, workflow automation, instrument and system integrations, file parsing, API connectivity, inventory management, client portals, automated reporting, analytics, and integrated Quality Management System (QMS) capabilities.
QBench is designed to adapt as laboratory processes change. Teams can modify workflows, fields, and automations without relying heavily on custom development.
As a cloud-based platform, QBench brings laboratory data, workflows, automation, quality management, and reporting into one centralized system. Customers are also supported by a team that includes former bench scientists who understand laboratory workflows and provide guidance during implementation and ongoing use.
Learn more
Claude Mythos 5.1
Claude Mythos 5.1 represents Anthropic's latest advancement in the Mythos-class of models, tailored for sophisticated applications in cybersecurity, biology, scientific investigation, programming, and extensive knowledge-oriented tasks. While it shares the same foundational architecture as Claude Fable 5.1, it is differentiated by unique safety measures: Fable 5.1 is widely accessible, whereas Mythos 5.1 is limited to select trusted access programs designed with specific safeguards for cybersecurity and life sciences research. This model establishes a new benchmark in performance for autonomous coding and showcases unparalleled cyber capabilities among all Anthropic models released thus far. In the realm of scientific research, Mythos 5.1 can effectively handle specialized tools and intricate workflows related to molecular design, computational biology, and various technical fields. During testing by Anthropic, it successfully engineered high-affinity protein binders for multiple targets, achieving its highest recorded hit rate to date. Additionally, it demonstrated proficiency in optimizing seven different open-source deep learning models focused on protein and genomics. By pushing the boundaries of what is possible, Mythos 5.1 is positioned to make significant contributions to future research and development endeavors.
Learn more
Recursion
Recursion is a leading TechBio innovator using artificial intelligence to radically improve how new medicines are discovered and developed. The company was founded on the idea that images of cells could be used to train AI systems to understand disease biology at scale. By combining data, machine learning models, and powerful computing, Recursion works to overcome the inefficiencies of traditional drug discovery. Its Recursion OS platform connects massive proprietary biological datasets with automated experimentation and AI-driven insights. This approach has produced a growing pipeline of potential therapies for oncology and rare diseases with high unmet medical needs. Recursion has demonstrated significant gains in speed, efficiency, and cost reduction compared to conventional pharmaceutical methods. Strategic partnerships with pharmaceutical companies and technology leaders expand the reach of its platform. The company also collaborates with NVIDIA to power its discovery efforts using BioHive-2, one of the most advanced supercomputers in biopharma. Together, these capabilities position Recursion as a leader in AI-driven drug discovery. Its ultimate goal is to deliver better medicines to patients through precision design and data-driven science.
Learn more